Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Ileal Anal Anastomosis and Ileal Pouch Fistulas in the Setting of Crohn's Disease of the Pouch

NCT04073472 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT04073472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04073472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Ileal Anal Anastomosis and Ileal Pouch Fistulas in the Setting of Crohn's Disease of the Pouch
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Withdrawn
Start date
June 1, 2021
Completion date
June 1, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anal fistula, crohn's disease, fistula, pouch, ileal, pouches, ileoanal